IP Verse

Becton Dickinson Infusion Therapy Systems patent opposition analysis

CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Latest patents of Becton Dickinson Infusion Therapy Systems opposed by its competitors

Explore Becton Dickinson Infusion Therapy Systems's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2325643
Dec 1, 2021Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xv1
EP2322930
Jul 14, 2021Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xiv1
EP2325647
Jul 14, 2021Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xx1
EP2325644
Jul 29, 2020Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xii2
EP2325645
Jul 29, 2020Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xiii2
EP2325646
Jan 30, 2019Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xvii1

Top competitors of Becton Dickinson Infusion Therapy Systems

List of top competitors of Becton Dickinson Infusion Therapy Systems based on patent oppositions.